Status:

COMPLETED

Blockade of Vascular Potassium Channels During Human Endotoxemia

Lead Sponsor:

Radboud University Medical Center

Collaborating Sponsors:

ZonMw: The Netherlands Organisation for Health Research and Development

Conditions:

Endotoxemia

Eligibility:

All Genders

18-35 years

Phase:

PHASE1

Brief Summary

Background: Activation of NO-synthase and vascular potassium (K) channels may play a role in the sepsis-induced attenuated sensitivity to norepinephrine. We examined whether various K channel blockers...

Eligibility Criteria

Inclusion

  • healthy volunteers

Exclusion

  • drug, alcohol, nicotine abuse

Key Trial Info

Start Date :

January 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2005

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT00185003

Start Date

January 1 2003

End Date

June 1 2005

Last Update

October 17 2008

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Blockade of Vascular Potassium Channels During Human Endotoxemia | DecenTrialz